COVID-19 Monoclonal Antibodies Paying for Administration and Better Evidence

Paying for Administration and Better Evidence Cover

COVID-19 Monoclonal Antibodies Paying for Administration and Better Evidence

Published date

December 10, 2020

Duke-Margolis Affiliated Authors

MHL

Marianne Hamilton Lopez, PhD, MPA

Senior Research Director, Biomedical Innovation
Faculty Director of the Duke-Margolis Postdoctoral Associates & Affiliated Fellows Program
Adjunct Associate Professor
Senior Team Member
Margolis Core Faculty

nitzan arad

Nitzan Arad, LLM

Area Lead for Drug Pricing and Competition Policy

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty